More children are treated in the U.S. with antibiotics for inflammation of the middle ear, or otitis media, than any other child health problem. More than five million cases are diagnosed every year. But now, a scholarly review of over one hundred studies by a U.Va. pediatrician concludes that antibiotics help only one in eight children with ear infections.
Dr. J. Owen Hendley, professor of pediatrics and a specialist in pediatric infectious diseases, writes in the Oct. 10 edition of the New England Journal of Medicine that placebo-controlled trials found ear infections had gone away in one week in 81 percent of placebo recipients, as compared with 94 percent of antibiotic recipients. Hendley says there is a clear downside to the use of antibiotics to treat common ear infections. "The bacteria which cause ear infections learn quickly to be resistant to antibiotics. At some point were going to run out of drugs to treat the problem," he says. "Antibiotic resistance is a huge problem in this country. The practice of treating eight children to help the one who needs antibiotics just makes it worse."
When they diagnose an ear infection, doctors should hold off giving antibiotics for 48 to 72 hours, Hendley advises, because the infection can clear up spontaneously. The pain and irritability that accompany ear infections should be treated with childrens acetaminophen, ibuprofen or other pain relievers. Hendley, however, found that an antibiotic, such as amoxicillin, is recommended for a less common ear infection, bacterial otitis media or "pus drum", characterized by bulging eardrums and visible pus.
Bob Beard | EurekAlert!
Finding new clues to brain cancer treatment
21.02.2020 | Case Western Reserve University
UIC researchers find unique organ-specific signature profiles for blood vessel cells
18.02.2020 | University of Illinois at Chicago
The operational speed of semiconductors in various electronic and optoelectronic devices is limited to several gigahertz (a billion oscillations per second). This constrains the upper limit of the operational speed of computing. Now researchers from the Max Planck Institute for the Structure and Dynamics of Matter in Hamburg, Germany, and the Indian Institute of Technology in Bombay have explained how these processes can be sped up through the use of light waves and defected solid materials.
Light waves perform several hundred trillion oscillations per second. Hence, it is natural to envision employing light oscillations to drive the electronic...
Most natural and artificial surfaces are rough: metals and even glasses that appear smooth to the naked eye can look like jagged mountain ranges under the microscope. There is currently no uniform theory about the origin of this roughness despite it being observed on all scales, from the atomic to the tectonic. Scientists suspect that the rough surface is formed by irreversible plastic deformation that occurs in many processes of mechanical machining of components such as milling.
Prof. Dr. Lars Pastewka from the Simulation group at the Department of Microsystems Engineering at the University of Freiburg and his team have simulated such...
Investigation of the temperature dependence of the skyrmion Hall effect reveals further insights into possible new data storage devices
The joint research project of Johannes Gutenberg University Mainz (JGU) and the Massachusetts Institute of Technology (MIT) that had previously demonstrated...
Researchers at Chalmers University of Technology, Sweden, recently completed a 5-year research project looking at how to make fibre optic communications systems more energy efficient. Among their proposals are smart, error-correcting data chip circuits, which they refined to be 10 times less energy consumptive. The project has yielded several scientific articles, in publications including Nature Communications.
Streaming films and music, scrolling through social media, and using cloud-based storage services are everyday activities now.
After helping develop a new approach for organic synthesis -- carbon-hydrogen functionalization -- scientists at Emory University are now showing how this approach may apply to drug discovery. Nature Catalysis published their most recent work -- a streamlined process for making a three-dimensional scaffold of keen interest to the pharmaceutical industry.
"Our tools open up whole new chemical space for potential drug targets," says Huw Davies, Emory professor of organic chemistry and senior author of the paper.
12.02.2020 | Event News
16.01.2020 | Event News
15.01.2020 | Event News
21.02.2020 | Medical Engineering
21.02.2020 | Health and Medicine
21.02.2020 | Physics and Astronomy